Erin Mackey
Medical · Beverly, MANPI 1003992629
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.8% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Johnson & Johnson at 28.0% of the total. 2025 is the largest year on record at $1,559, more than ten times the $47 reported in 2021. Among medical clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 124 payments — averaging $30.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- AbbVie$924
- UCB, Inc.$322
- Galderma Laboratories, L.p.$237
- Regeneron Healthcare Solutions, Inc.$190
- E.r. Squibb & Sons, L.L.C.$185
- plus $906 from 12 others
What the payments were for
- Food & beverage$3,48691%
- Education$3529%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 20 | $1,075 |
| AbbVie | 40 | $924 |
| UCB, Inc. | 6 | $322 |
| Galderma Laboratories, L.p. | 16 | $237 |
| Regeneron Healthcare Solutions, Inc. | 4 | $190 |
| E.r. Squibb & Sons, L.L.C. | 4 | $185 |
| Ferring Pharmaceuticals Inc. | 1 | $147 |
| Sun Pharmaceutical Industries Inc. | 5 | $145 |
| Janssen Scientific Affairs, LLC | 1 | $114 |
| Organon | 9 | $99 |
| Novartis | 5 | $99 |
| Amgen | 4 | $91 |
| Lilly USA, LLC | 2 | $51 |
| Pfizer | 2 | $47 |
| LEO Pharma Inc. | 2 | $43 |
| Sanofi | 1 | $30 |
| Verrica Pharmaceuticals Inc. | 1 | $21 |
| Botanix SB Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,838 in reported general payments places this provider in the 90th percentile of 421 medical providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 32 | $127,105 |
| Tacrolimus | 28 | $3,077 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 38 | $1,267 |
| Clindamycin Phosphate | 18 | $784 |
| Ketoconazole | 43 | $584 |
| Triamcinolone Acetonide | 50 | $539 |
| Mometasone Furoate | 12 | $237 |
| Nystatin | 11 | $146 |
| Hydroxyzine Hcl | 12 | $121 |
Paid to pharmacies, not to this prescriber.
Other medical in Beverly
- Ariana SelbyBeverly$6K
- Eileen CheeverLeominster$389K
- Vidal PrimiterioLawrence$22K
- Michelle BaytarianJamaica Plain$17K
- Julia FioreAgawam$16K
- Jennifer LevesqueFall River$15K
- Ashley HoffmanWestfield$13K
- Theresa FukudaBoston$13K
- Christina MessingerPlymouth$11K
- Lauren CarraSpringfield$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.